Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Combining PRP with low-level laser therapy is better for hair growth than PRP alone.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Tacrolimus can cause hair loss in kidney transplant patients.

Certain peptides, caffeine, taurine, and an iron complex may improve hair regrowth when used with minoxidil and finasteride for hair loss.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

Understanding WNT signaling proteins can help predict and treat certain types of hair loss.

Photobiomodulation effectively stimulates hair growth and reduces hair loss.

Minoxidil can cause unwanted hair growth, so personalized care and support are important.

Retinoic acid helps change skin cells and is important for skin development and hair growth.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.